The preliminary study on the relationship between HPV-associated cervical cancer and p53 codon 72 polymorphism in Sichuan province

Storey A, Thomas M, Kalita A,et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature, 1998, 393: 229–234.

Rosenthal AN, Ryan A, Al-Jehani RM,et al. p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet, 1998, 352: 871–872.

Thomas M, Massimi P, Jenkins J,et al. HPV-18 E6 mediated inhibition of p53DNA binding activity is independent of E6 induced degradation. Oncogene, 1995, 10: 261–268.

Milner J, Medcalf EA. Cotranslation of activated mutant p53 with wild-type drives the wild-type p53 protein into the mutant conformation. Cell, 1991, 65: 765–774.

Yu H, Chen JK, Feng S,et al. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell, 1994, 76: 933–945.